


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 9 Jan 2008
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
BioAlliance Pharma Receives Market Approval for Loramyc(R) in the United Kingdom and Denmark
HSMN NewsFeed - 8 Jan 2008
Candela Names Scott Blood Vice President of Quality Assurance and Regulatory Affairs
Candela Names Scott Blood Vice President of Quality Assurance and Regulatory Affairs
HSMN NewsFeed - 8 Jan 2008
Quintiles Names Head of Strategic Research, Medical, Regulatory, and Safety Services
Quintiles Names Head of Strategic Research, Medical, Regulatory, and Safety Services
HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
HSMN NewsFeed - 21 Dec 2007
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
ISENTRESS(R) (raltegravir) from MSD, First Integrase Inhibitor, Approved by the European Union Commission
HSMN NewsFeed - 20 Dec 2007
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed - 19 Dec 2007
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
Avastin Approved in Europe for First-Line Treatment of Patients With Advanced Kidney Cancer
HSMN NewsFeed - 14 Dec 2007
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
HSMN NewsFeed - 14 Dec 2007
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
OSI Pharmaceuticals Announces Launch Date of Tarceva(R) (erlotinib) in Japan
HSMN NewsFeed - 11 Dec 2007
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
Artes Medical Names Karon J. Morell as Vice President, Regulatory and Quality Affairs
HSMN NewsFeed - 6 Dec 2007
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
Micrus Endovascular Receives Approval to Market Stretch-Resistant Microcoils in Japan
HSMN NewsFeed - 5 Dec 2007
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 4 Dec 2007
Criticare Announces the MEDRAD(R) Veris(R) MR Monitoring System is Approved for Marketing in Japan
Criticare Announces the MEDRAD(R) Veris(R) MR Monitoring System is Approved for Marketing in Japan
HSMN NewsFeed - 3 Dec 2007
CSMG Technologies Live Tissue Connect Subsidiary Receives CE Mark for New VAD.400 RF Generator
CSMG Technologies Live Tissue Connect Subsidiary Receives CE Mark for New VAD.400 RF Generator
HSMN NewsFeed - 30 Nov 2007
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
Health Canada Approves Conceptus' Third Generation Essure(R) Permanent Birth Control System
HSMN NewsFeed - 27 Nov 2007
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
Introgen's ADVEXIN Advances as Marketing Authorization Application is Accepted for Review in Europe
HSMN NewsFeed - 27 Nov 2007
Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan
Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan
HSMN NewsFeed - 27 Nov 2007
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
Gendux Announces Acceptance of Its ADVEXIN Marketing Authorization Application for Review by the EMEA
HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 20 Nov 2007
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
Nephros Receives Approval to Market OLpur(TM) MD Hemodiafilter Series in Canada
HSMN NewsFeed - 16 Nov 2007
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
HSMN NewsFeed - 16 Nov 2007
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology
HSMN NewsFeed - 16 Nov 2007
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
UCB to Appeal European Negative Opinion on CIMZIA(R) for the Treatment of Patients with Crohn's Disease
